Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.
Year: 1997
Type: article
Abstract: The use of inhaled nitric oxide as a selective pulmonary vasodilator has expanded to include patients with congenital heart disease and pulmonary hypertension. The therapeutic and diagnostic roles of inhaled nitric oxide offer additional alternatives and benefits to these patients with pulmonary hypertension, particularly in the postoperative setting. This article reviews the background, mechanism of action, toxicities, and current clinical applications of inhaled nitric oxide in the child with congenital heart disease and pulmonary hypertension.
Source: Europe PMC (PubMed Central)
Authors: J P Kovalchin, A R Mott, K L Rosen, T F Feltes
Institution: Baylor College of Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W11852000